MDR1 genotypes do not influence the absorption of a single oral dose of 1 mg digoxin in healthy white males.
about
Pharmacogenetics in chronic heart failure: new developments and current challengesPharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision MedicineATP-binding cassette B1 gene polymorphisms, mRNA expression and chemosensitivity to paclitaxel in non-small cell lung cancer cells.Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance gene 1A mutation-centric approach to identifying pharmacogenomic relations in text.Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis.Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters.Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)Implications of pharmacogenetics for individualizing drug treatment and for study design.Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs.MDR1 haplotypes derived from exons 21 and 26 do not affect the steady-state pharmacokinetics of tacrolimus in renal transplant patients.Meta-analysis of the influence of MDR1 C3435T polymorphism on digoxin pharmacokinetics and MDR1 gene expression.The effect of CYP2J2, CYP3A4, CYP3A5 and the MDR1 polymorphisms and gender on the urinary excretion of the metabolites of the H-receptor antihistamine ebastine: a pilot studyA case for pharmacogenomics in management of cardiac arrhythmias.Pharmacogenetics-based new therapeutic concepts.Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patientsMechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.The pharmacogenetics of calcineurin inhibitors: one step closer toward individualized immunosuppression?Interindividual epigenetic variation in ABCB1 promoter and its relationship with ABCB1 expression and function in healthy Chinese subjectsGenetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCG2: therapeutic implications.Single nucleotide polymorphisms in human P-glycoprotein: its impact on drug delivery and disposition.Pharmacogenetic differences and drug-drug interactions in immunosuppressive therapy.ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research.Discordant associations between SLCO1B1 521T→C and plasma levels of ritonavir-boosted protease inhibitors in AIDS clinical trials group study A5146.The emerging importance of transporter proteins in the psychopharmacological treatment of the pregnant patient.Gender and interindividual variability in pharmacokinetics.Overview of pharmacogenetics.Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development.The impact of genetic factors on response to glucocorticoids therapy in IBD.Practical Pharmacogenomic Approaches to Heart Failure Therapeutics.Pharmacogenomics of heart failure: a systematic review.P-glycoprotein: a clue to vitamin K antagonist stabilization.Gefitinib-phenytoin interaction is not correlated with the C-erythromycin breath test in healthy male volunteersInfluence of ABCB1 gene polymorphisms on the pharmacokinetics of verapamil among healthy Chinese Han ethnic subjectsHuman intestinal P-glycoprotein activity estimated by the model substrate digoxin.Effect of the MDR1 C3435T variant and P-glycoprotein induction on dicloxacillin pharmacokinetics.Genomic evidence for recent positive selection at the human MDR1 gene locus.MDR1 haplotypes do not affect the steady-state pharmacokinetics of cyclosporine in renal transplant patients.Improvement of Adequate Digoxin Dosage: An Application of Machine Learning Approach
P2860
Q26852239-6455CEA2-F140-4C09-BAD6-40E5EDC02253Q27692687-B169FDE9-CB99-4F2E-AF03-3E18B3CE34FFQ27851666-CABF4CB4-9F8C-4548-8D15-722440A5154AQ28286926-CC37702E-FB2E-4EC9-97D6-49A3FCF3ED18Q31063941-3210EE5D-EFAF-4FAE-B7EC-65B36D0D3170Q34538009-0551F0A4-BB05-4367-8A86-CC8CA4C38C7AQ34568808-28AD3C52-AC4A-40AD-B46A-0F9DA7EA5409Q34994901-0929E1F1-095F-4202-974D-081F60776507Q35102211-1A72C6E6-A6D6-466B-AD02-3994B5639482Q35164664-C6042D36-7DD8-4E5C-9F5A-17881E380D8BQ35826490-CE45E1E3-0EE3-4659-9159-6C09B304573CQ35827187-53CA8179-72E6-40D8-9A33-03BEC6679070Q35827669-C412869A-22E1-4CA3-9A87-BFAB675221AEQ35914690-8BA7F36E-D80E-405D-9D08-973AA1FC3D97Q35956177-8B1E618D-3212-4DFC-9A5F-0A1D66BA57ACQ36024688-89F0C035-4AE6-41CF-BF4C-2DD381A8F784Q36120816-FFE6763C-492D-49A7-97F9-620F6DABA728Q36186945-BE7EE694-1D5C-4D33-83EE-CC4D39968133Q36243658-E63A6CD9-A530-4FDE-A700-A79D50D74BE3Q36301589-00B24E9E-1402-4631-A7E0-D4B021630E0BQ36349672-3A257AB4-1B5D-424C-A9F0-34109CC223D8Q36544981-F0C4E00D-638D-4C93-B702-CEC04B013899Q36592129-66940650-0E04-4EFE-8497-4205184127C0Q36701911-B4897986-1496-45EC-AE03-64DE95C48BBAQ37024001-206F1347-1257-4E0B-BBED-E4A8F96D6765Q37550556-80BA94F9-6299-441F-BC96-01AFF2F106E1Q37938905-D3C4F45E-77F2-407E-B956-6B895C5C5C4CQ38003174-2004536B-11E5-43FB-A616-A27D385AD371Q38699711-C235E4C3-C6CD-4B2F-8101-E14C9F8E0F4EQ38827323-7EF4D86E-7519-42A2-B60F-D63FECB7CF81Q38998634-C4B8BF35-9CC4-4878-9CE4-AB6683AF842DQ41535282-014FA10B-1F87-46C1-84FA-7DE1DA56A342Q42106492-68C902D4-2F11-41D8-B55B-A40D40A9C651Q42246055-4111E8CF-4A36-4B5E-B2E5-3E965C56D9ACQ42614867-DC59B25E-A00E-4373-82A7-51FF95447CD2Q45939354-CBC55027-6137-4A05-9743-032BF7B0E287Q46509410-E2F917BE-881C-44E2-A2C7-EC8E17E11097Q52949277-BB312EF4-C7C7-456B-ADE0-078581442C36Q58766132-F906C18F-5603-4AD1-816F-62EB906FE49C
P2860
MDR1 genotypes do not influence the absorption of a single oral dose of 1 mg digoxin in healthy white males.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
MDR1 genotypes do not influenc ...... igoxin in healthy white males.
@ast
MDR1 genotypes do not influenc ...... igoxin in healthy white males.
@en
type
label
MDR1 genotypes do not influenc ...... igoxin in healthy white males.
@ast
MDR1 genotypes do not influenc ...... igoxin in healthy white males.
@en
prefLabel
MDR1 genotypes do not influenc ...... igoxin in healthy white males.
@ast
MDR1 genotypes do not influenc ...... igoxin in healthy white males.
@en
P2093
P2860
P1476
MDR1 genotypes do not influenc ...... igoxin in healthy white males.
@en
P2093
Andreas Johne
Christian Meisel
Ingolf Cascorbi
Ivar Roots
Melanie Schaefer
Thomas Gerloff
P2860
P304
P356
10.1046/J.1365-2125.2002.01691.X
P407
P577
2002-12-01T00:00:00Z